<DOC>
	<DOCNO>NCT01304498</DOCNO>
	<brief_summary>Primary objective : â€¢ To demonstrate administration V503 induce non-inferior Geometric Mean Titers ( GMTs ) ( serum anti-HPV16 anti-HPV18 ) compare GARDASIL . Secondary objective : - To evaluate tolerability V503 9-15 year-old girl . - To summarize humoral immune response ( anti-HPV 6 , 11 , 16 , 18 ) induce V503 GARDASIL .</brief_summary>
	<brief_title>Immunogenicity Tolerability V503 Versus GARDASIL</brief_title>
	<detailed_description />
	<criteria>Female 9 15 year old . Good physical health . Known allergy vaccine component . History severe allergic reaction . Thrombocytopenia coagulation disorder would contraindicate intramuscular injection . Pregnant subject . Immunocompromised immunodeficient subject . Splenectomy . Receipt medication / vaccine may interfere study assessment . Fever History positive test HPV , prior receipt HPV vaccine prior participation HPV trial . Any condition might interfere study assessment .</criteria>
	<gender>Female</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>